Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Indeed they do. Easier money for a doc to be a highly paid expert FUDster, than actually practicing medicine. Perhaps his retirement plan.
All of today's FUD postings this morning was nothing more than to provide cover for a planned takedown.
You do know that these FUDsters are all paid to be here working for a collusive HF organization... right?
It's no secrete.
FYI... Anavex will be granted approval in both Rett and AD next year. The ongoing OLE will serve as the confirmatory trial (as Missling mentioned) in the AA pathway. Mark it!
It's too funny to see you jumping in here all of a sudden with some sort of instant "expertise" on the subject. LOL
IGNORE!
REPEAT: They have not dropped the Odds Ratios! Only a FUDster would make that ridiculous claim.
The ORs are still valid in highlighting the Super Responders!
Your tripe is getting rather old.
LOL... still measuring himself by his parents' approval. Too funny!
Another P3 isn't likely to happen. Missling stating that OLE may serve as the confirmatory trial wasn't made with tongue in cheek. It was likely stated because of recent conversations with the FDA when reviewing the pivotal P3 data.
The Odds Ratios haven't been "dropped". They're still valid and served a purpose of highlighting the SUPER RESPONDERS. That hasn't changed.
LOL... a drop-in FUDster from the NWBO MB. Too funny!
LOL. Sounds like someone complaining because the Twinkie was left out of their lunchbox.
FUDsters only focus on the minutia.
The big picture are the key biomarkers, which make AA highly likely, with confirmatory trial (OLE) in progress.
It doesn't get any better than this!
Pure nonsense as usual from you.
The P2b/3 met all endpoints, regardless of the ORs, which were supplementary.
No way could the company change its definition of success, as some FUDsters here are suggesting. That's ridiculous.
The only reason AD NDA might lag Rett is because of the PR voucher.
AD AA is virtually a given with the OLE serving as the confirmatory trial.
Come on, Schmig, you're making way too much of the grammar when the meaning was quite clear.
Get over it!
Yes, be investors... ignore the exhaustive FUD.
I most certainly do believe what the company has stated multiple times. And now we have further evidence of amazing data, plus key biomarkers.
It doesn't get any better than this!
But FUDsters will continue their made-up nonsense... don't you?
LOL... I'm just a dedicated FUDster flagger. And you've been flagged!
FUDsters ignore the meaningful data and biomarker findings that'll lead to AA... with OLE becoming a confirmatory trial.
But you have a job to do. I get it.
Appreciate your confession of collusive manipulation...
still not a $8 stock and it has as always nothing at all to do with how Anavex readout
Looks like they are having a little bit of a battle holding AVXL underneath $8 as I type this. My suspicion is that we will close very near $8 tomorrow.
It's just FUD narratives when posters scoff at the significant OR calculations that identify super responders, which no other AD P3 has ever produced.
Today's updated data detailed the stat. sig. results of the overall treated population, and more importantly, the identified biomarkers that will be used for the AA pathway... with OLE serving as the confirmatory trial.
Biotech isn't fantasyland, but it's certainly home to collusive manipulation with its paid FUDsters.
Patience... approval first, then partnerships.
Posters with valid comments I listen to; however, posters who make up FUD to create a false "fumbled" narrative are ones to be wary of, as they have an ulterior motive.
Biotech investing isn't for everyone... especially for those who can't see the manipulation.
sab, don't believe the FUD nonsense coming from known resident FUDsters.
When collusive manipulation controls the price, it's a good guess the price will continue to be contained.
It happened again today; Imagine that...
https://www.sec.gov/comments/s7-29-22/s72922-20153799-321641.pdf
The Anatomy of a Short Attack – Abusive shorting are not random acts of a renegade hedge funds, but rather a coordinated business plan that is carried out by a collusive consortium of hedge funds and prime brokers, with help from their friends at the DTC and major clearinghouses. Potential target companies are identified, analyzed and prioritized. The attack is planned to its most minute detail.
Yeah, different levels, alright: Mine is the TRUTH level; yours is the FUD level.
You have me on ignore, but still reading. LOL
True, it will come... but expect continued collusive manipulation, accompanied by the typical daily FUD, until closer to approval.
No... yours is the big LIE.
The problem is that he LIES! ORs also turned out to the whole big BS after AUC.
Hold your FUD; the details are yet to come... stay tuned for the peer-review.
What happened to stick to the plan: peer-reviewed the results/paper before announcing the details?
There's that damn FUD seagull again... we just cleaned up his crap from yesterday. Geez!
Leave it to our most prominent FUDsters to continue with the ridiculous "fumbling" narrative.
Add that term to the FUD list that includes, "cherry picking", "moved goalposts", "flawed data", etc.
FUD nonsense as usual
It's rather obvious and stated by Missling... 30mg as effective as 50mg for most patients, especially WT.
Where have you been?
Bullshit! It's all collusive shorting by your HF handlers.
I've heard and read everything Missling has publicly commented on and never have I heard him say that.
I never heard that and don't believe it to be true. Please provide the link.
It was supplementary data.
Why is collusive shorting so effective? It costs nothing to short... no investment.
It helps to have AF and other FUDsters pen lies as cover.
It should be illegal... it only serves the criminals.
Agree... scientific measurements of improvement are more valuable than subjective testing, especially in a short 48-wk trial.
There wasn't a pivot away from the OR calculations. They served their purpose in identifying the super responders. Nothing more to be added there.
For Anavex to PR the additional P2b/3 AD data ahead of Rett results, tells me we're going to see more AD results this year.
The collusive manipulation machine is working hard to short it back down...
Anavex has to leave something for the peer-reviewed journal. Those details are coming...
Correct... AF is hired to write the lying hit pieces as cover for the collusive operation.
You can bet he has one pre-written for the Rett TLD.
Judging by the earlier scripting between 12x and Investor, it'll be a conspiracy on the RSBQ endpoint. Just wait... "CHANGED ENDPOINT!"